According to the KEGG analysis, the Toll-like receptor, MAPK, PI3K-Akt, TNF, NOD-like, NF-κB, and renin-angiotensin signaling pathways are major targets of GJD in the treatment of hypertension. This evidence concerns the gene TNF and Hypertension.